Technion Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovations and know-how in exosome production suited for many clinical applicationsTORONTO and HAIFA, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, proudly underscores its expanding Intellectual Property (IP) portfolio, which will serve as the foundation for its strategic goal of licensing the innovative ExoTherapy platform to interested biotech companies. NurExone’s Intellectual

Prof. Shulamit Levenberg from the Haifa Technion-Israel Institute of Technology is among the few Israeli women scientists who have invented the most innovative technologies and registered patents.

CSRankings, which ranks top computer science institutions around the world, has named the Technion the top university in Europe for AI.

Automated analysis of routine ECG detects cardiac problems Researchers say their method shows “unprecedented accuracy in the interpretation of numerous ECG results and delivers a diagnosis of different cardiac disorders simultaneously.” Prof. Yael Yaniv and her research team. Photo courtesy of Technion Spokesperson’s Office Technion-Israel Institute of Technology researchers have developed a way to detect heart problems based on routine electrocardiography (ECG). They have also built a database and an analytic tool to provide an automated diagnosis of eight common types of heart disease...